Accelerated Discovery of Potent Fusion Inhibitors for Respiratory Syncytial Virus
- 10 April 2020
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 6 (5) , 922-929
Abstract
A series of five benzimidazole-based compounds were identified using a machine learning algorithm as potential inhibitors of the respiratory syncytial virus (RSV) fusion protein. These compounds were synthesized, and compound 2 in particular exhibited excellent in vitro potency with an EC50 value of 5 nM. This new scaffold was then further refined leading to the identification of compound 44, which exhibited a 10-fold improvement in activity with an EC50 value of 0.5 nM.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI071002)
- National Institute of Child Health and Human Development (HD079327)
This publication has 35 references indexed in Scilit:
- Respiratory Syncytial Virus—A Comprehensive ReviewClinical Reviews in Allergy & Immunology, 2013
- Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008Clinical Infectious Diseases, 2012
- Requirements for Human Respiratory Syncytial Virus Glycoproteins in Assembly and Egress from Infected CellsAdvances in Virology, 2011
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivoBioorganic & Medicinal Chemistry Letters, 2009
- Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moietyBioorganic & Medicinal Chemistry Letters, 2007
- Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailabilityBioorganic & Medicinal Chemistry Letters, 2007
- Respiratory Syncytial Virus Infection in Elderly and High-Risk AdultsNew England Journal of Medicine, 2005
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the United StatesJAMA, 2003
- Respiratory Syncytial Virus Infection in AdultsClinical Microbiology Reviews, 2000